A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

NCT01806376 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Subutinib Maleate capsules

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Collaborators

[object Object]